Search research articles
Contact Us
Filters
Showing results (151-160 of 288) with videos related to
Page
of 29
Sort By:
The Journal of Antimicrobial Chemotherapy
|
June 22, 2019
Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study)
Antonella Castagna, Camilla Muccini, Laura Galli, et al.
Annals of Neurology
|
May 4, 2004
The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations
Paola Cinque, Manuela Nebuloni, Maria Lisa Santovito, et al.
The New Microbiologica
|
January 3, 2006
In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients
Nicola Gianotti, Laura Galli, Enzo Boeri, et al.
Journal of the International AIDS Society
|
November 15, 2014
Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression
Alessia Carbone, Laura Galli, Alba Bigoloni, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
July 30, 2013
Optimal dietary calcium intake in HIV treated patients: no femoral osteoporosis but higher cardiovascular risk
Laura Galli, Alessandro Rubinacci, Deborah Cocorullo, et al.
Blood
|
January 18, 2003
Expression of CD4 on human peripheral blood neutrophils
Priscilla Biswas, Barbara Mantelli, Antonio Sica, et al.
The Journal of Infectious Diseases
|
August 10, 2006
Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study
Daria Podlekareva, Amanda Mocroft, Ulrik B Dragsted, et al.
The Lancet. HIV
|
October 2, 2015
Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study
Jean-Michel Molina, Bonaventura Clotet, Jan van Lunzen, et al.
Journal of Medical Virology
|
September 15, 2007
Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1
Hamid Hasson, Barbara Mantelli, Priscilla Biswas, et al.
AIDS (London, England)
|
August 28, 2014
Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy
Laura Galli, Vincenzo Spagnuolo, Andrea Poli, et al.
Page
of 29
Search research articles
Search
Showing results (151-160 of 288) with videos related to
Sort By:
Page
of 29
The Journal of Antimicrobial Chemotherapy
|
June 22, 2019
Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study)
Antonella Castagna, Camilla Muccini, Laura Galli, et al.
Annals of Neurology
|
May 4, 2004
The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations
Paola Cinque, Manuela Nebuloni, Maria Lisa Santovito, et al.
The New Microbiologica
|
January 3, 2006
In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients
Nicola Gianotti, Laura Galli, Enzo Boeri, et al.
Journal of the International AIDS Society
|
November 15, 2014
Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression
Alessia Carbone, Laura Galli, Alba Bigoloni, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
July 30, 2013
Optimal dietary calcium intake in HIV treated patients: no femoral osteoporosis but higher cardiovascular risk
Laura Galli, Alessandro Rubinacci, Deborah Cocorullo, et al.
Blood
|
January 18, 2003
Expression of CD4 on human peripheral blood neutrophils
Priscilla Biswas, Barbara Mantelli, Antonio Sica, et al.
The Journal of Infectious Diseases
|
August 10, 2006
Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study
Daria Podlekareva, Amanda Mocroft, Ulrik B Dragsted, et al.
The Lancet. HIV
|
October 2, 2015
Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study
Jean-Michel Molina, Bonaventura Clotet, Jan van Lunzen, et al.
Journal of Medical Virology
|
September 15, 2007
Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1
Hamid Hasson, Barbara Mantelli, Priscilla Biswas, et al.
AIDS (London, England)
|
August 28, 2014
Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy
Laura Galli, Vincenzo Spagnuolo, Andrea Poli, et al.
Page
of 29